Gold nanoparticle imaging and radiotherapy of brain tumors in mice

Nanomedicine

Volumn 8, Issue 10, 2013, Pages 1601-1609

  Hainfeld, James F ^a   Smilowitz, Henry M ^b   O'connor, Michael J ^a   Dilmanian, Farrokh Avraham ^c,d   Slatkin, Daniel N ^a  

^a Nanoprobes Incorporated   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

brain tumor; cancer; contrast agent; dose enhancement; glioma; gold nanoparticle; imaging; microcomputed tomography; radiotherapy; x ray

Indexed keywords

GOLD NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CANCER RADIOTHERAPY; CONTROLLED STUDY; GLIOBLASTOMA; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; GLIOMA; GOLD; HUMANS; KAPLAN-MEIER ESTIMATE; METAL NANOPARTICLES; MICE; RADIATION DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84885145508     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.165     Document Type: Article

References (38)

1. Beier D, Schulz JB, Beier CP. Chemoresistance of glioblastoma cancer stem cells: Much more complex than expected. Mol. Canc. 10, 128 (2011).
2. Mrugala MM, Adair JE, Kiem HP. Outside the box: Novel therapeutic strategies for glioblastoma. Cancer J. 18(1), 51-58 (2012).
3. Liu HL, Yang HW, Hua MY, Wei KC. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: An overview of the current preclinical status. Neurosurg. Focus 32(1), E4 (2012).
4. Parvez T. Present trend in the primary treatment of aggressive malignant glioma: Glioblastoma multiforme. Technol. Cancer Res. Treat. 7(3), 241-248 (2008).
5. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49(18), N309-N315 (2004).
6. Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. Radiotherapy enhancement with gold nanoparticles. J. Pharm. Pharmacol. 60(8), 977-985 (2008).
7. Kong T, Zeng J, Wang X et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small 4(9), 1537-1543 (2008).
8. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res. 60(16), 4440-4445 (2000).
9. McMahon SJ, Mendenhall MH, Jain S, Currell F. Radiotherapy in the presence of contrast agents: A general figure of merit and its application to gold nanoparticles. Phys. Med. Biol. 53(20), 5635-5651 (2008).
10. Zhang SX, Gao J, Buchholz TA et al. Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: A Monte Carlo simulation study. Biomed. Microdevices 11(4), 925-933 (2009).
11. Spiers FW. The influence of energy absorption and electron range on dosage in irradiated bone. Br. J. Radiol. 22, 521-533 (1949).
12. Matsudaira H, Ueno AM, Furuno I. Iodine contrast-medium sensitizes cultured mammalian-cells to x-rays but not to gamma-rays. Radiat. Res. 84(1), 144-148 (1980).
13. Santos Mello R, Callisen H, Winter J, Kagan AR, Norman A. Radiation dose enhancement in tumors with iodine. Med. Phys. 10(1), 75-78 (1983).
14. Norman A, Ingram M, Skillen RG et al. X-ray phototherapy for canine brain masses. Radiat. Oncol. Investig. 5(1), 8-14 (1997).
15. Rose JH, Norman A, Ingram M et al. First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx). Int. J. Radiat. Oncol. Biol. Phys. 45(5), 1127-1132 (1999).
16. Rousseau J, Adam JF, Deman P et al. Intracerebral delivery of 5-iodo-2'-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma. J. Synchrotron. Radiat. 16(Pt 4), 573-581 (2009).
17. Edouard M, Broggio D, Prezado Y et al. Treatment plans optimization for contrast-enhanced synchrotron stereotactic radiotherapy. Med. Phys. 37(6), 2445-2456 (2010).
18. Adam JF, Joubert A, Biston MC et al. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 64(2), 603-611 (2006).
19. Regulla DF, Hieber LB, Seidenbusch M. Physical and biological interface dose effects in tissue due to x-ray-induced release of secondary radiation from metallic gold surfaces. Radiat. Res. 150(1), 92-100 (1998).
20. Cho SH. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: A preliminary Monte Carlo study. Phys. Med. Biol. 50(15), N163-N173 (2005).
21. Herold DM, Das IJ, Stobbe CC, Iyer RV, Chapman JD. Gold microspheres: A selective technique for producing biologically effective dose enhancement. Int. J. Radiat. Biol. 76(10), 1357-1364 (2000).
22. Hainfeld J, Dilmanian F, Zhong Z, Slatkin D, Smilowitz HM. Gold nanoparticles enhance radiation therapy of a squamous cell carcinoma growing in mice. Phys. Med. Biol. 55, 3045 (2010).
23. Weissenberger J, Steinbach JP, Malin G et al. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene 14(17), 2005-2013 (1997).
24. Smilowitz HM, Weissenberger J, Weis J et al. Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: Establishment of a new transplantable in vivo model for malignant glioma. J. Neurosurg. 106(4), 652-659 (2007).
25. Black KL, Yin D, Ong JM et al. PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model. Brain Res. 1230, 290-302 (2008).
26. Geraci JP, Sun MC, Mariano MS. Amelioration of radiation nephropathy in rats by postirradiation treatment with dexamethasone and/or captopril. Radiat. Res. 143(1), 58-68 (1995).
27. Hainfeld JF, O'Connor MJ, Dilmanian FA et al. Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Br. J. Radiol. 84(1002), 526-533 (2011).
28. Noguchi Y, Wu J, Duncan R et al. Early phase tumor accumulation of macromolecules: A great difference in clearance rate between tumor and normal tissues. Jpn J. Cancer Res. 89(3), 307-314 (1998).
29. McMahon SJ, Hyland WB, Muir MF et al. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiother. Oncol. 100(3), 412-416 (2011).
30. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: A new x-ray contrast agent. Br. J. Radiol. 79(939), 248-253 (2006).
31. Popovtzer R, Agrawal A, Kotov NA et al. Targeted gold nanoparticles enable molecular CT imaging of cancer Nano Lett. 8(12), 4593-4596 (2008).
32. Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R. Targeted gold nanoparticles enable molecular CT imaging of cancer: An in vivo study. Int. J. Nanomed. 6, 2859-2864 (2011).
33. Veiseh M, Gabikian P, Bahrami SB et al. Tumor paint: A chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. 67(14), 6882-6888 (2007).
34. Qian X, Peng XH, Ansari DO et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 26(1), 83-90 (2008).
35. Shukla R, Bansal V, Chaudhary M et al. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 21(23), 10644-10654 (2005).
36. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1(3), 325-327 (2005).
37. Kim JK, Seo SJ, Kim KH et al. Therapeutic application of metallic nanoparticles combined with particle-induced x-ray emission effect. Nanotechnology 21(42), 425102 (2010).
38. Cho SH, Jones BL, Krishnan S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources. Phys. Med. Biol. 54(16), 4889-4905 (2009).